The $30 Billion Mammoth: Inside Colossal’s Quest to Price Sci-Fi as Infrastructure
Colossal Biosciences is reportedly seeking a valuation up to $30 billion. But is this a play for ecological restoration, or a highly speculative bet on genetic IP?
5 min read